Pharmaceutical industry news

Update on escalating conflict in the Eastern Mediterranean Region

17 March 2026 – Conflict in the Middle East continues to escalate, unfolding a multi-layered public...

WHO releases US$2 million in emergency funds to support health response in Lebanon, Iraq and Syria

15 March 2026, Cairo, Egypt — As humanitarian health needs continue to rise across parts of the Midd...

Conflict deepens health crisis across Middle East, WHO says

WHO Representative in Lebanon and team visit the Dekwaneh shelter in Beirut, hosting internally disp...

Statement by Dr Hanan Balkhy, Regional Director WHO Eastern Mediterranean Region Palais Briefing on Impact of the recent escalation on the health situation in EMR

6 March 2026Today, 115 million people across the Eastern Mediterranean Region require humanitarian a...

Statement by Dr Hanan Balkhy, WHO Regional Director at the Director-General’s Press Conference

5 March 2026Dear Director General, dear excellencies ministers of health and dear colleagues,The sit...

WHO Eastern Mediterranean Region and Pan American Health Organization sign agreement to strengthen hospital resilience

Cairo, Egypt, 25 February 2026 — WHO’s Regional Office for the Eastern Mediterranean (EMRO) and the...

WHO EMRO and Lebanese American University partner to advance IPC and AMR education

23 February 2026, Cairo, Egypt — The World Health Organization Regional Office for the Eastern Medit...

WHO and Boston University partner to tackle environmental-driven antimicrobial resistance in displaced communities

18 February 2026, Cairo-Egypt - The World Health Organization (WHO) Regional Office for the Eastern...

WHO validates elimination of trachoma as a public health problem in Libya

Photo credit: National Committee for the Prevention of blindness, Ministry of health LibyaGeneva | C...

WHO and Islamic Development Bank deepen collaboration to scale health investments across the region

WHO and IsDP meeting to explore enhanced collaboration and opportunities to scale health investments...

Director of Research appointed30 January 2026Globally recognised clinical neurologist and translational neuroscientist, Prof Terry O'Brien has been appointed as the new Director of Research for Bayside Health's Alfred Care Group.brainresearch & innovation

Globally recognised clinical neurologist and translational neuroscientist, Prof Terry O'Brien has be...

World-leading scanner is a gamechanger for patients and research9 February 2026Meet Karen, one of the first patients to be scanned using our new world-class advanced total body Quadra PET scanner.braincancerclinical trialsmelanomapatientsradiologyresearch & innovation

Meet Karen, one of the first patients to be scanned using our new world-class advanced total body Qu...

Companioning for better health outcomes16 February 2026A partnership between The Alfred’s Hospital Admissions Risk Program (HARP) and charity Social Health Australia (SHA) is improving health outcomes by pairing patients with volunteer ‘companions’.patients

A partnership between The Alfred’s Hospital Admissions Risk Program (HARP) and charity Social Health...

A global exchange in life-saving care19 February 2026The Alfred recently welcomed Ukraine’s leading heart transplant team, with clinicians using the opportunity to share experiences, surgical techniques and demonstrate new technology driving transplant medicine forward globally.heartresearch & innovationstafftransplant

The Alfred recently welcomed Ukraine’s leading heart transplant team, with clinicians using the oppo...

The Alfred named one of the world’s best hospitals27 February 2026The Alfred has once again been recognised among the world’s leading hospitals, earning a place in Newsweek’s World’s Best Hospitals 2026 rankings.patientsresearch & innovationstaff

The Alfred has once again been recognised in Newsweek’s World’s Best Hospitals 2026 rankings

Are you active in your community and interested in quality healthcare?2 March 2026Call for Applications for Membership of Bayside Health Community Advisory Committeepatients

Alfred Health - Providing leading healthcare for the people of Melbourne and Victoria.

World-leading melanoma imaging research earns national honour2 March 2026A research network tasked with paving the way to better understand, manage and treat melanoma has been awarded the 2026 Universities Australia 'Shaping Australia' Problem Solver Award. a { text-decoration: none; color: #464feb; } tr th, tr td { border: 1px solid #e6e6e6; } tr th { background-color: #f5f5f5; }cancermelanomaresearch & innovation

A research network tasked with paving the way to better understand, manage and treat melanoma has be...

For Chelsey: Elisha raises money in memory of her sister6 March 2026For Elisha King, raising money in memory of her sister, Chelsey, was in part about raising awareness of deep vein thrombosis (DVT) through The Alfred and partly a healing process for herself.bleeding & clottingbloodeducationfundraisingpatientsresearch & innovationthe alfred foundation

For Elisha King, raising money in memory of her sister, Chelsey, was in part about raising awareness...

The Alfred goes trackside at F16 March 2026Everyone at emergency and radiology knows orderly Mike O’Brien loves motor racing — and not just because he dresses up come Grand Prix season.emergency & traumapatients

Located just down the road from The Alfred, The Grand Prix Medical Centre is fully equipped to deliv...

Management of Women’s and Newborn Services moving to Bayside Health20 March 2026The management of Women’s and Newborn Services at Sandringham Hospital will transfer from Monash Health to Bayside Health in the second half of 2026.patientssandringhamwomen's health

Alfred Health - Providing leading healthcare for the people of Melbourne and Victoria.

LKCMedicine and CUHK GCNI deepen partnership to advance brain healthPublished on20 Mar 2026

LKCMedicine and CUHK GCNI deepen partnership to advance brain health

Newsletters and Magazines

LKCMedicine Magazines and Newsletters

EngineeringESE research provides insights into breast cancer tissue processing20 March 2026

Generic Drug Labeling Carve-Out Scorecard

By Kurt R. Karst – With the recent litigation surrounding FDA’s approval of ANDAs for generic versio...

US FDA Probes Skin Reactions With CNPV Approval Of Novo Nordisk’s Wegovy Higher Dose

Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated...

Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

Public list of companies in the UK who have had their licence/registration to manufacture or wholesa...

EU Urged Again To Act Now And Restore Biopharma Competitiveness

Guidance: Archiving and retention of clinical trial records

Information on clinical trial record retention and archiving requirements including requirements for...

Guidance: Declaration of Helsinki and Clinical Trial Regulations alignment

Information on the alignment of the amended UK clinical trial legislation with the Declaration of He...

Guidance: Clinical Trials Regulations enforcement provisions

Information about Clinical Trials Regulations outlining expanded enforcement provisions, offences, a...

Kintor’s KX-826 meets phase III endpoints in alopecia

Kintor Pharmaceutical Ltd.’s topical androgen receptor antagonist, pyrilutamide (KX-826), met the pr...

EMA Rolls Out Trio Of Tools To Accelerate Drug Development Under PRIME Scheme

Magnosolv - Granulat

Rückruf aufgrund nicht eingemeldeter Seriennummern

eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical

Officials at eXoZymes, which focuses on cell-free manufacturing and the development of AI-enhanced “...

Cognito Shows Off More Positive Data For Device-Based Alzheimer’s Treatment

Cognito Therapeutics has revealed data from its OVERTURE feasibility study backing up the ability of...

Leica Biosystems Accelerates Aperio AI Store Growth, Expands AI-Tools, and Welcomes Mindpeak to Its Growing Ecosystem

Lynavoy (linerixibat) approved by the US FDA for cholestatic pruritus in patients with primary biliary cholangitis (PBC)

Approval based on the positive GLISTEN phase III trial with regulatory reviews underway in the EU, U...

Read Articleabout "Beyond the scale: The real story behind weight loss and metabolic health"

AdventHealth’s Metabolic Health Institute’s Dr. Damon Tanton unpacks what metabolic health truly mea...

Resources for Journalists

Our team is here to assist journalists by providing resources; such as, faculty experts, news releas...

CUROSURF 240, 1 vial de 3 ml (NR: 59600, CN: 778191)

Formato pdf Fecha de publicación: 19 de marzo de 2026 Nº alerta: R_13/2026 Fecha: 18 de marzo de 202...

Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes

For the primary endpoint, retatrutide lowered A1C by an average of 1.7% to 2.0% across doses at 40 w...

PRAC assesses that NAION could be a very rare side effect of Ozempic, Rybelsus and Wegovy

EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) recommends that the product information for...

FAGG lanceert dashboard met actuele cijfers en statistieken voor klinische proeven

The FAMHP is launching a dashboard with up-to-date figures and statistics for clinical trials Public...

Kintor’s Male Hair Loss Drug Returns With Phase III Win

Kintor's topical androgen receptor inhibitor KX-826 posts win in China Phase III trial in male andro...

Chugai Files for the Medical Device Component of the Port Delivery Platform with ranibizumab in Japan

Application filed in Japan for the medical device component (ocular implant and ancillary devices) i...

革新的な眼内インプラントを用いたラニビズマブ（Port Delivery Platform with ranibizumab）、国内で医療機器部分の製造販売承認申請

ラニビズマブ（ Port Delivery Platform with ranibizumab ）について、医療機器部分（インプラントおよび付属品）における国内製造販売承認申請を実施 本医療機器承認申...

Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

Global data from over 12,000 consumers signals the future of modern aesthetics will be multimodal tr...

Chugai Selected as a “Nadeshiko Brand” for FY2025

TOKYO, March 19, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that it has been se...

中外製薬、令和7年度「なでしこ銘柄」に選定

中外製薬株式会社 （本社：東京、代表取締役社長 CEO：奥田 修）は、女性活躍推進に優れた上場企業として、経済産業省と東京証券取引所より、令和7年度「なでしこ銘柄」に選定されましたのでお知らせいたしま...

Innate Pharma announces conference call and webcast for full year 2025 financial results

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), today announce...

Mindpeak Announces Global Reseller Agreement with Leica Biosystems to Expand Access to AI Pathology Solutions

How Spring Cleaning Can Lift Your Mood

Cleveland Clinic, a non-profit academic medical center, provides clinical and hospital care and is a...

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2026 on Thursday, Ap...

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe

ACCESS ALL PRESS RELEASES

SFDA CEO Congratulates the Saudi Leadership on Eid al-Fitr

H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), on his own behalf and...

Subscribe to Press release email alerts

Sign up for BMY email alerts and receive timely updates on press releases.

View latest results

Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

Growing Base Business Evolving Into More Durable Portfolio of Higher-Margin Generics, Value-Added Me...

03.19.2026Press ReleaseIR NewsNotice of Board of Director and Corporate Auditor Nominations

March 19, 2026, Osaka, Japan - Santen Pharmaceutical Co., Ltd. (hereinafter Santen) at a Board of Di...

12.23.2025Press ReleaseIR NewsSanten Launches Verkazia® (Ciclosporin Eye Drops (III) ) in China For the Treatment of Severe Vernal Keratoconjunctivitis (VKC) in Children and Young Adults

December 23, 2025 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (hereinafter Santen) today announ...

InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

ZURZUVAE® Capsules 30 mg for the Treatment of Major Depressive Disorder launched in Japan

OSAKA, Japan, March 19, 2026 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Offi...

Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease

OSAKA, Japan, March 19, 2026 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Offi...

Media resources

Discover our company announcements and press releases. media resources and investor and media contac...

Passion for pharma

Doorheen 2026 geeft pharma.be via een reeks video’s het woord aan verschillende geëngageerde collega...

ask@pharma.be

De farmaceutische industrie wil graag een antwoord bieden op de talloze vragen die je je wellicht st...

New doctoral thesisPhysical violence in sexual assaults is increasing among young peoplePhysical violence in sexual assaults against young people has become more common and more severe. This is shown in a new doctoral thesis. The studies cover both women and men and point to the need for clearer clinical procedures and better education about consent.

Physical violence in sexual assaults against young people has become more common and more severe. Th...

New studyExercise and nutritional drinks can reduce the need for care in dementiaA simple combination of daily physical exercise and protein-rich nutritional drinks appears to offer significant health benefits for people with dementia. In a new study, not only did the participants' physical ability improve, but after three months the researchers also saw signs that they were able to manage more everyday tasks themselves.

A simple combination of daily physical exercise and protein-rich nutritional drinks appears to offer...

New studyHigh risk of readmission and death among heart failure patientsAlmost half of patients hospitalised for acute heart failure in Europe are readmitted within a year, according to a new study. The risk of death also remains high, especially for those with more severely reduced heart function.

Almost half of patients hospitalised for acute heart failure in Europe are readmitted within a year,...

Eight KI researchers receive Marie Skłodowska-Curie grants in record competitionEight young researchers at Karolinska Institutet have been awarded Curie grants within the EU's Marie Skłodowska-Curie Actions (MSCA). This means strengthened opportunities to conduct research that can contribute to future medical breakthroughs – from the role of mitochondria in disease to the brain's body experience and new strategies for allergy treatment.

Eight young researchers at Karolinska Institutet have been awarded postdoctoral grants within the EU...

Four innovation grants awarded to KI by the Knut and Alice Wallenberg FoundationFour innovation projects at KI in the field of life science receive funding from the Knut and Alice Wallenberg Foundation and SciLifeLab's Proof-of-Concept program. The grants aim to strengthen the path from academic research to innovation and commercial application in life science.

Four innovation projects at KI in the field of life science receive funding from the Knut and Alice...

StockphotoAI research at KI paves the way for more targeted and globally equal healthcareArtificial Intelligence that detects breast cancer, enables medical imaging in low-resource countries and that identifies the patients who require advanced treatment even at the point of diagnosis – these are just a few examples of AI research at Karolinska Institutet that is impacting an entire world.

Artificial Intelligence that detects breast cancer, enables medical imaging in low-resource countrie...

Appetite suppressants are reshaping the landscapeA minority of Swedes are within the normal weight range, while one in five is obese. New, effective drugs have drastically changed the possibilities for treatment. This may lead to a better understanding of the disease, perhaps even among patients themselves.First published in the magazine Medicinsk Vetenskap no 1 2026.

A minority of Swedes are within the normal weight range, while one in five is obese. New, effective...

New studyCommon drug class may increase risk of heart diseasePeople who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease. This is shown in a new study from Karolinska Institutet.

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urin...

New studyScreening improves early detection of colorectal cancerMore cases of colorectal cancer are detected at an early stage with screening, according to a randomised clinical trial by researchers at Uppsala University and Karolinska Institutet. The study has been published inNature Medicine.

More cases of colorectal cancer are detected at an early stage with screening, according to a random...

New studyHydrocortisone may reduce the risk of lung disease in extremely premature babiesEarly treatment with hydrocortisone may increase the chance that extremely premature babies will survive without the chronic lung disease bronchopulmonary dysplasia (BPD), according to a study by researchers at Linköping University and Karolinska Institutet.

Early treatment with hydrocortisone may increase the chance that extremely premature babies will sur...

New studyThe uterus' immune system can regenerate after transplantationThe immune system in the uterus can regenerate after both uterus transplantation and bone marrow transplantation, according to a new study from Karolinska Institutet. The new insights into how the uterine immune environment functions may be significant for the treatment of infertility and complications during pregnancy.

The immune system in the uterus can regenerate after both uterus transplantation and bone marrow tra...

New studyHPV vaccine provides long-term protection against cervical cancerHPV vaccination reduces the risk of cervical cancer for at least 18 years, according to a new study. There were no signs of waning protection over time.

HPV vaccination reduces the risk of cervical cancer for at least 18 years, according to a new study...

US donation to Jon Lampa for research into potential new treatment for rheumatoid arthritisA private donation from Sally Cahill, USA, to researchers at Karolinska Institutet could make a new treatment for severe rheumatoid arthritis a reality. The method, which involves stimulating a nerve in the ear with a weak electric signal, has so far delivered promising results.

A private donation from Sally Cahill, USA, to researchers at Karolinska Institutet could make a new...

EXOZ investor update: eXoZymes de-risks scale-up with Cayman Chemical, validating tech transfer with pharma-grade output

Los Angeles, CA -- March 18, 2026 -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of...

A High-Quality Testing Portfolio Grounded in Science – A Research Recap

At Foundation Medicine, we have a rich history of scientific firsts in comprehensive genomic profili...

Mar 18, 2026 4:30 PM EDTXOMA Royalty Declares Quarterly Preferred Stock Dividends

Medical devices: get regulatory advice from the MHRA

How to apply for a regulatory advice meeting on medical devices and in vitro diagnostic devices.

Guidance: COVID-19 test validation approved products

Find out which COVID-19 test products have been approved.

Decision: Parallel import licences granted in 2026

Parallel import licences granted in 2026.

Decision: Marketing authorisations Granted in 2026

Marketing authorisations Granted in 2026.

Regulation: Improving Patient Information

MHRA's Improving Patient Information project aims to modernise how medicines product information is...